
About Arene Life Sciences (Unit 4) Private Limited
Data last updated:
Arene Life Sciences (Unit 4) Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC151189.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satyanarayana Reddy Chinnamail and Satyanarayana Reddy Khairtabad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 3 – 58 S.R. Chambers Main Road Ramachandrapuram Medak, Hyderabad, Telangana, India – 502032.
For more details, the company can be reached via its website arenelifesciences.com.
Company details
Contact details
Arene Life Sciences (Unit 4) Private Limited's registered office is in Hyderabad, Telangana. Its website is arenelifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH. No. 3 – 58 S.R. Chambers Main Road Ramachandrapuram Medak, Hyderabad, Telangana, India – 502032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Arene Life Sciences (Unit 4) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arene Life Sciences (Unit 4) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Arene Life Sciences (Unit 4) Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Arene Life Sciences (Unit 4) Private Limited, buy the company report.
Board of directors of Arene Life Sciences (Unit 4) Private Limited
Arene Life Sciences (Unit 4) has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Reddy Chinnamail Also directs: Srduo Infra LLP, S.R. Drugs and Intermediates Pvt.Ltd., S.R. Drugs and Intermediates (Unit 3) Private Limited and 5 more | Director | 05 May 2021 | 5 Years 6 Months | Current |
| Satyanarayana Reddy Khairtabad Also directs: Srduo Infra LLP, Satya Sharada Ventures LLP, S.R. Drugs and Intermediates Pvt.Ltd. and 5 more | Director | 05 May 2021 | 5 Years 6 Months | Current |
Peer comparison
Arene Life Sciences (Unit 4) Private Limited is compared with the 5 companies closest to it by revenue in the Business Services industry (Business Auxiliary Services, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Scott-Edil Advance Research Laboratories & Education Limited | ₹418.23 Cr (FY 2025) | 17.0% | Chandigarh, India | |||
| Visa Drugs & Pharmaceuticals Private Limited | ₹414.04 Cr (FY 2016) | 32.0% | Kolkata, West Bengal, India | |||
| Skymap Pharmaceuticals Private Limited | ₹409.08 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| United Biotech Private Limited | ₹404.94 Cr (FY 2024) | 27.0% | New Delhi, Delhi, India | |||
| Zeiss Pharmaceuticals Private Limited | ₹403.65 Cr (FY 2025) | 6.0% | Nalagarh, Himachal Pradesh, India |
To see the full peer comparison of Arene Life Sciences (Unit 4) Private Limited, buy the company report.
Auditor
Arene Life Sciences (Unit 4) Private Limited is audited by GLN Prasad & Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GLN Prasad & Co LLP | FY 2023 | 015176S/S200067 |
Shareholding
The shareholding of Arene Life Sciences (Unit 4) Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Arene Life Sciences (Unit 4) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arene Life Sciences (Unit 4) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arene Life Sciences (Unit 4) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Arene Life Sciences (Unit 4) Private Limited has 1 active EPFO establishment as of Nov 11, 2026.
GST
No GST registration is on our record for Arene Life Sciences (Unit 4) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Arene Life Sciences (Unit 4) Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Satyanarayana Reddy Chinnamail was appointed as Director on 05 May 2021.
Frequently asked questions
Arene Life Sciences (Unit 4) is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 2021 (5+ years old) and is registered under CIN U24290TG2021PTC151189.
Arene Life Sciences (Unit 4) has 2 current directors:
- Satyanarayana Reddy Chinnamail - Director
- Satyanarayana Reddy Khairtabad - Director
The latest financial statements of Arene Life Sciences (Unit 4) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Arene Life Sciences (Unit 4) is U24290TG2021PTC151189. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arene Life Sciences (Unit 4) was incorporated on 05 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Arene Life Sciences (Unit 4) by revenue are Scott-Edil Advance Research Laboratories & Education Limited, Visa Drugs & Pharmaceuticals Private Limited, Skymap Pharmaceuticals Private Limited, United Biotech Private Limited, Zeiss Pharmaceuticals Private Limited, all in the Business Services industry (Business Auxiliary Services, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satyanarayana Reddy Chinnamail was appointed as Director on 05 May 2021. Satyanarayana Reddy Khairtabad was appointed as Director on 05 May 2021.
Arene Life Sciences (Unit 4) can be reached through the website arenelifesciences.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Arene Life Sciences (Unit 4) is at H. No. 3 – 58 S.R. Chambers Main Road Ramachandrapuram Medak, Hyderabad, Telangana, India – 502032.
Arene Life Sciences (Unit 4) operates in the pharma industry, in the drug formulation and development segment.
Arene Life Sciences (Unit 4) is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

